Delivery Order SPE2DB20D9371-SPE2DB25FT1U9

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.42 firm fixed-price delivery order is for the supply of 4,566,779,622 tablets of Fexofenadine HCL 180 mg, with a completion date of December 6, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $2,460.12 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,324,784 tablets of the pharmaceutical drug Fexofenadine HCL 180 mg and has a completion date of January 31, 2025. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,872.80, is for the delivery of 4,567,372,728 units of Fexofenadine HCL 180 mg tablets by February 21, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $1,923.36, for the delivery of FEXOFENADINE HCL 180 MG TABLET 500S. The contract has an ultimate completion date of January 13, 2025. This award is not associated with a specific set-aside designation. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and an ultimate completion date of February 10, 2025. The contract is for the supply of 4,567,248,727 units of Fexofenadine HCL 180 mg tablets, a pharmaceutical product. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 4,567,133,666 units of Fexofenadine HCL 180 mg tablets to support the medical supply needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DX24FAFN1) under the larger SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 with the Defense Logistics Agency (DLA). The contract is for the delivery of a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
This federal contract award is for a Firm Fixed Price Delivery Order (SPE2DB21FQ56K) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,629.60 and covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is part of a larger Indefinite...
  • SPE2DB20D9371
    Indefinite Delivery Contract
  • SPE2DB20D9371-SPE2DB25FT1U9
    Delivery Order

This federal contract award is a delivery order (SPE2DB20D9371|SPE2DB25FT1U9) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and covers the delivery of 4,567,005,555 units of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price award, with a period of performance through January 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue delivery orders for a range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This specific contract award is not associated with a set-aside designation.

Generated 4/18/25, 1:54 AM